Langerholc, Ward, Stefano Announce Legislation to Reform Pharmacy Benefit Managers - pasenategop.com
New legislation announced to reform Pharmacy Benefit Managers (PBMs) in Pennsylvania, impacting pharmacy operations and reimbursement processes.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Pennsylvania. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Legislation aims to reform the operations and regulations surrounding Pharmacy Benefit Managers, which may affect reimbursement rates and pharmacy operations.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Pennsylvania.
What you must do
Stay informed about the specifics of the legislation as it develops and prepare for potential changes in PBM interactions.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Major reforms to Alabama Board of Pharmacy narrowly pass committee - aldailynews.com
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - reedsmith.com
- Lawmakers want pharmacists involved with South Dakota's medical marijuana system - argusleader.com
- Pharmacy Board Bans Designer Drugs In Oregon - opb.org
- Fifth Circuit Stay Reinstates Nationwide In-Person Dispensing Requirement for Mifepristone - reedsmith.com